BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15332275)

  • 1. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
    Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
    J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
    Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
    Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
    Marr AK; Jenssen H; Moniri MR; Hancock RE; Panté N
    Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
    Andersen JH; Jenssen H; Gutteberg TJ
    Antiviral Res; 2003 May; 58(3):209-15. PubMed ID: 12767468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
    Ammendolia MG; Marchetti M; Superti F
    Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate.
    Jenssen H; Andersen JH; Uhlin-Hansen L; Gutteberg TJ; Rekdal Ø
    Antiviral Res; 2004 Feb; 61(2):101-9. PubMed ID: 14670583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
    Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
    Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
    Drobni P; Näslund J; Evander M
    Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
    Marchetti M; Ammendolia MG; Superti F
    Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
    Chien YJ; Chen WJ; Hsu WL; Chiou SS
    Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors.
    Jenssen H; Gutteberg TJ; Lejon T
    J Pept Sci; 2005 Feb; 11(2):97-103. PubMed ID: 15635641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate.
    Waarts BL; Aneke OJ; Smit JM; Kimata K; Bittman R; Meijer DK; Wilschut J
    Virology; 2005 Mar; 333(2):284-92. PubMed ID: 15721362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-papillomavirus activity of human and bovine lactoferricin.
    Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
    Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
    Di Biase AM; Pietrantoni A; Tinari A; Siciliano R; Valenti P; Antonini G; Seganti L; Superti F
    J Med Virol; 2003 Apr; 69(4):495-502. PubMed ID: 12601757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
    Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
    Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.
    Albiol Matanic VC; Castilla V
    Int J Antimicrob Agents; 2004 Apr; 23(4):382-9. PubMed ID: 15081088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
    Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
    Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.